The Underlying Biology and Therapeutic Vulnerabilities of Leptomeningeal Metastases in Adult Solid Cancers

Metastasis to the central nervous system occurs in approximately 20% of patients with advanced solid cancers such as lung cancer, breast cancer, and melanoma. While central nervous system metastases most commonly form in the brain parenchyma, metastatic cancer cells may also reside in the subarachno...

Full description

Bibliographic Details
Main Authors: Matthew Dankner, Stephanie Lam, Theresa Degenhard, Livia Garzia, Marie-Christine Guiot, Kevin Petrecca, Peter M. Siegel
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/4/732
_version_ 1797411689907355648
author Matthew Dankner
Stephanie Lam
Theresa Degenhard
Livia Garzia
Marie-Christine Guiot
Kevin Petrecca
Peter M. Siegel
author_facet Matthew Dankner
Stephanie Lam
Theresa Degenhard
Livia Garzia
Marie-Christine Guiot
Kevin Petrecca
Peter M. Siegel
author_sort Matthew Dankner
collection DOAJ
description Metastasis to the central nervous system occurs in approximately 20% of patients with advanced solid cancers such as lung cancer, breast cancer, and melanoma. While central nervous system metastases most commonly form in the brain parenchyma, metastatic cancer cells may also reside in the subarachnoid space surrounding the brain and spinal cord to form tumors called leptomeningeal metastases. Leptomeningeal metastasis involves cancer cells that reach the subarachnoid space and proliferate in the cerebrospinal fluid compartment within the leptomeninges, a sequela associated with a myriad of symptoms and poor prognosis. Cancer cells exposed to cerebrospinal fluid in the leptomeninges must contend with a unique microenvironment from those that establish within the brain or other organs. Leptomeningeal lesions provide a formidable clinical challenge due to their often-diffuse infiltration within the subarachnoid space. The molecular mechanisms that promote the establishment of leptomeningeal metastases have begun to be elucidated, demonstrating that it is a biological entity distinct from parenchymal brain metastases and is associated with specific molecular drivers. In this review, we outline the current state of knowledge pertaining to the diagnosis, treatment, and molecular underpinnings of leptomeningeal metastasis.
first_indexed 2024-03-09T04:49:42Z
format Article
id doaj.art-4aeefdb86554408ba0dcb394a7476e82
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T04:49:42Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-4aeefdb86554408ba0dcb394a7476e822023-12-03T13:11:17ZengMDPI AGCancers2072-66942021-02-0113473210.3390/cancers13040732The Underlying Biology and Therapeutic Vulnerabilities of Leptomeningeal Metastases in Adult Solid CancersMatthew Dankner0Stephanie Lam1Theresa Degenhard2Livia Garzia3Marie-Christine Guiot4Kevin Petrecca5Peter M. Siegel6Goodman Cancer Research Centre, Faculty of Medicine, McGill University, Montreal, QC H3A 1A3, CanadaDepartment of Diagnostic Radiology, Faculty of Medicine, Research Institute of the McGill University Health Centre, Montreal, QC H3T 1E2, CanadaDepartment of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 2B4, CanadaResearch Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, CanadaGoodman Cancer Research Centre, Faculty of Medicine, McGill University, Montreal, QC H3A 1A3, CanadaDepartment of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, Goodman Cancer Research Centre, McGill University, Montreal, QC H3A 2B4, CanadaGoodman Cancer Research Centre, Faculty of Medicine, McGill University, Montreal, QC H3A 1A3, CanadaMetastasis to the central nervous system occurs in approximately 20% of patients with advanced solid cancers such as lung cancer, breast cancer, and melanoma. While central nervous system metastases most commonly form in the brain parenchyma, metastatic cancer cells may also reside in the subarachnoid space surrounding the brain and spinal cord to form tumors called leptomeningeal metastases. Leptomeningeal metastasis involves cancer cells that reach the subarachnoid space and proliferate in the cerebrospinal fluid compartment within the leptomeninges, a sequela associated with a myriad of symptoms and poor prognosis. Cancer cells exposed to cerebrospinal fluid in the leptomeninges must contend with a unique microenvironment from those that establish within the brain or other organs. Leptomeningeal lesions provide a formidable clinical challenge due to their often-diffuse infiltration within the subarachnoid space. The molecular mechanisms that promote the establishment of leptomeningeal metastases have begun to be elucidated, demonstrating that it is a biological entity distinct from parenchymal brain metastases and is associated with specific molecular drivers. In this review, we outline the current state of knowledge pertaining to the diagnosis, treatment, and molecular underpinnings of leptomeningeal metastasis.https://www.mdpi.com/2072-6694/13/4/732brain metastasisleptomeningeal metastasessubarachnoid spacebreast cancerlung cancermelanoma
spellingShingle Matthew Dankner
Stephanie Lam
Theresa Degenhard
Livia Garzia
Marie-Christine Guiot
Kevin Petrecca
Peter M. Siegel
The Underlying Biology and Therapeutic Vulnerabilities of Leptomeningeal Metastases in Adult Solid Cancers
Cancers
brain metastasis
leptomeningeal metastases
subarachnoid space
breast cancer
lung cancer
melanoma
title The Underlying Biology and Therapeutic Vulnerabilities of Leptomeningeal Metastases in Adult Solid Cancers
title_full The Underlying Biology and Therapeutic Vulnerabilities of Leptomeningeal Metastases in Adult Solid Cancers
title_fullStr The Underlying Biology and Therapeutic Vulnerabilities of Leptomeningeal Metastases in Adult Solid Cancers
title_full_unstemmed The Underlying Biology and Therapeutic Vulnerabilities of Leptomeningeal Metastases in Adult Solid Cancers
title_short The Underlying Biology and Therapeutic Vulnerabilities of Leptomeningeal Metastases in Adult Solid Cancers
title_sort underlying biology and therapeutic vulnerabilities of leptomeningeal metastases in adult solid cancers
topic brain metastasis
leptomeningeal metastases
subarachnoid space
breast cancer
lung cancer
melanoma
url https://www.mdpi.com/2072-6694/13/4/732
work_keys_str_mv AT matthewdankner theunderlyingbiologyandtherapeuticvulnerabilitiesofleptomeningealmetastasesinadultsolidcancers
AT stephanielam theunderlyingbiologyandtherapeuticvulnerabilitiesofleptomeningealmetastasesinadultsolidcancers
AT theresadegenhard theunderlyingbiologyandtherapeuticvulnerabilitiesofleptomeningealmetastasesinadultsolidcancers
AT liviagarzia theunderlyingbiologyandtherapeuticvulnerabilitiesofleptomeningealmetastasesinadultsolidcancers
AT mariechristineguiot theunderlyingbiologyandtherapeuticvulnerabilitiesofleptomeningealmetastasesinadultsolidcancers
AT kevinpetrecca theunderlyingbiologyandtherapeuticvulnerabilitiesofleptomeningealmetastasesinadultsolidcancers
AT petermsiegel theunderlyingbiologyandtherapeuticvulnerabilitiesofleptomeningealmetastasesinadultsolidcancers
AT matthewdankner underlyingbiologyandtherapeuticvulnerabilitiesofleptomeningealmetastasesinadultsolidcancers
AT stephanielam underlyingbiologyandtherapeuticvulnerabilitiesofleptomeningealmetastasesinadultsolidcancers
AT theresadegenhard underlyingbiologyandtherapeuticvulnerabilitiesofleptomeningealmetastasesinadultsolidcancers
AT liviagarzia underlyingbiologyandtherapeuticvulnerabilitiesofleptomeningealmetastasesinadultsolidcancers
AT mariechristineguiot underlyingbiologyandtherapeuticvulnerabilitiesofleptomeningealmetastasesinadultsolidcancers
AT kevinpetrecca underlyingbiologyandtherapeuticvulnerabilitiesofleptomeningealmetastasesinadultsolidcancers
AT petermsiegel underlyingbiologyandtherapeuticvulnerabilitiesofleptomeningealmetastasesinadultsolidcancers